EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
   3.2.1.169 | Central Nervous System Diseases |
30783492 |
Diazaspirononane Inhibitors of O-GlcNAc Hydrolase for the Treatment of Central Nervous System Diseases. |
causal interaction
therapeutic application
unassigned |
3
4
0 |
| 3.2.1.169 | Insulin Resistance |
20130445 |
O-GlcNAc-selective-N-acetyl-beta-D-glucosaminidase activity and mRNA expression in muscle is related to glucosamine-induced insulin resistance. |
diagnostic usage
ongoing research
unassigned |
1
4
0 |
| 3.2.1.169 | Insulin Resistance |
23983178 |
Proteomics and PUGNAcity will overcome questioning of insulin resistance induction by non-selective inhibition of O-GlcNAcase. |
therapeutic application
unassigned |
2
0 |
| 3.2.1.169 | Stomach Neoplasms |
29196265 |
Elevated O-GlcNAcylation stabilizes FOXM1 by its reduced degradation through GSK-3? inactivation in a human gastric carcinoma cell line, MKN45 cells. |
diagnostic usage
ongoing research
unassigned |
3
3
0 |
